IMB Impact - Industry
Subscribe now to recieve regular news and event updates from IMB.
"I would like to make the diagnostics of many diseases, including prostate cancer, as simple as it is today for diabetes."
What is your research focus?
By applying engineering principles to biology, my research group work to develop new technologies to detect abnormalities in the body simply and efficiently.
Is prostate cancer difficult to detect?
Prostate cancer is the most easily diagnosed and the most over treated cancer. The main problem with Prostate Cancer is distinguishing between slow growing and non-invasive tumors, which are the majority, and the small number of aggressive rapidly growing tumors.
What do you hope to achieve through your research?
We aim to give doctors and patients cheap and easy diagnostic tests that help them to detect, classify and monitor prostate cancer.
I would like to make the diagnostics of many diseases, including prostate cancer, as simple as it is today for diabetes. We are currently developing a diagnostic device patients can simply insert into a mobile phone and read their diagnosis.
How will this improve outcomes for those with prostate cancer?
We expect that it will increase the accuracy of the diagnosis and also simplify the long term monitoring of the condition. This is very important, as watchful waiting is one of the main approaches to the detection of Prostate Cancer.
Monitoring cancer bio-markers post surgery is essential for long-term survival, yet only about 50% of men adhere to annual tests. The ability to provide the patient with a self diagnosis tool and monitor self performed tests over the internet is expected to significantly improve long term survival.
What inspires you to use technology to help combat disease like prostate cancer?
I am motivated to give patients more control over and access to their information.
If you would like to help progress this technology to provide men with a simple tool to rapidly detect and monitor prostate cancer, please donate today.
Innovation - Translation - Impact
Click here to read the full newsletter
IMB is sharpening focus on translation and innovation
IMB has a strong track record in world class scientific research and discovery that is advancing new treatments and diagnostics for global health, and improving products and processes for industry and the environment.
IMB Director Professor Brandon Wainwright elected as new chair of European Molecular Biology Laboratory (EMBL) Australia